• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NEU

NEUREN PHARMACEUTICALS LIMITED - Announcements

1.31% ! $17.78
Market Cap $2.240B  !

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

Announcements



NEU Neuren receives ethics approval to start Concussion trialPRICE SENSITIVE10/07/14 download Created with Sketch. 103.23KB
NEU Neuren completes enrolment in Phase 2 trial in Rett SyndromePRICE SENSITIVE26/06/14 download Created with Sketch. 99.27KB
NEU Appendix 3B25/06/14 download Created with Sketch. 154.27KB
NEU Neuren appoints CMC expert to leadership team23/06/14 download Created with Sketch. 107.99KB
NEUNeuren receives new US patent for NNZ-2591PRICE SENSITIVE04/06/14 download Created with Sketch. 94.34KB
NEUAppendix 3B03/06/14 download Created with Sketch. 157.88KB
NEUAppendix 3B03/06/14 download Created with Sketch. 157.89KB
NEUAppendix 3B30/05/14 download Created with Sketch. 154.2KB
NEUNeuren presents at International Meeting for Autism Research21/05/14 download Created with Sketch. 2.73MB
NEUAppendix 3B14/05/14 download Created with Sketch. 154.21KB
NEUAppendix 4C - quarterlyPRICE SENSITIVE30/04/14 download Created with Sketch. 55.39KB
NEUAppendix 3B30/04/14 download Created with Sketch. 154.35KB
NEUAGM Results of Meeting30/04/14 download Created with Sketch. 60.27KB
NEUChairman's AGM Address to Shareholders30/04/14 download Created with Sketch. 323.39KB
NEUPresentation at Morgans Emerging Companies Conference02/04/14 download Created with Sketch. 573.38KB
NEUAppendix 3B27/03/14 download Created with Sketch. 129.34KB
NEUNotice of Annual General Meeting/Proxy Form27/03/14 download Created with Sketch. 422.95KB
NEUAnnual Report to shareholders27/03/14 download Created with Sketch. 3.31MB
AAI +S&P DJ Indices Announces March Quarterly Rebalance07/03/14 download Created with Sketch. 98KB
NEUNeuren reports financial results for 201327/02/14 download Created with Sketch. 144.7KB
NEUPreliminary Final Report and audited Financial StatementsPRICE SENSITIVE27/02/14 download Created with Sketch. 2.45MB
NEUAppendix 3B21/02/14 download Created with Sketch. 154.65KB
NEUAppendix 3B14/02/14 download Created with Sketch. 154.93KB
NEUAppendix 4C - quarterlyPRICE SENSITIVE31/01/14 download Created with Sketch. 55.23KB
NEUNeuren reports progress in NNZ-2566 clinical trial programsPRICE SENSITIVE28/01/14 download Created with Sketch. 121.3KB
NEUAppendix 3B15/01/14 download Created with Sketch. 154.76KB
NEUAppendix 3B02/01/14 download Created with Sketch. 155.33KB
NEUAppendix 3B29/11/13 download Created with Sketch. 154.88KB
NEUAppendix 3B27/11/13 download Created with Sketch. 155.05KB
NEUNeuren Share Purchase Plan raises $2 million27/11/13 download Created with Sketch. 95.96KB
NEUCeasing to be a substantial holder20/11/13 download Created with Sketch. 78.04KB
NEUInvestor presentation, 19 November 201319/11/13 download Created with Sketch. 331.59KB
NEUAppendix 3B15/11/13 download Created with Sketch. 155.08KB
NEUChange in substantial holding14/11/13 download Created with Sketch. 128.51KB
NEUAppendix 3B12/11/13 download Created with Sketch. 155.24KB
NEUChange of Director's Interest Notice06/11/13 download Created with Sketch. 35.23KB
NEUShare Purchase Plan record date04/11/13 download Created with Sketch. 26.48KB
NEUSPP Certification04/11/13 download Created with Sketch. 36.59KB
NEUAppendix 3B04/11/13 download Created with Sketch. 155.46KB
NEUBecoming a substantial holder31/10/13 download Created with Sketch. 147.32KB
NEUShare Purchase Plan offer documentsPRICE SENSITIVE30/10/13 download Created with Sketch. 360.05KB
NEUAppendix 4C - quarterlyPRICE SENSITIVE30/10/13 download Created with Sketch. 73.31KB
NEUOrphan drug designation from FDA for NNZ-2566 in Fragile XPRICE SENSITIVE30/10/13 download Created with Sketch. 99.4KB
NEUSection 708A(5)e Notice28/10/13 download Created with Sketch. 27.16KB
NEUAppendix 3B28/10/13 download Created with Sketch. 155.83KB
NEUPlacement of $21.5m to accelerate execution of strategyPRICE SENSITIVE22/10/13 download Created with Sketch. 101.31KB
NEUNeuren receives Fast Track designation for Fragile XPRICE SENSITIVE18/10/13 download Created with Sketch. 97.96KB
NEUTrading HaltPRICE SENSITIVE18/10/13 download Created with Sketch. 50.9KB
NEUAppendix 3B10/10/13 download Created with Sketch. 129.23KB
NEUResponse to ASX Price QueryPRICE SENSITIVE09/10/13 download Created with Sketch. 75.1KB
NEUInvestor presentation09/10/13 download Created with Sketch. 680.75KB
NEUNeuren data presented at Fragile X Foundation meeting01/10/13 download Created with Sketch. 954.86KB
NEUAppendix 3B26/09/13 download Created with Sketch. 129.09KB
NEUChange of Director's Interest Notice19/09/13 download Created with Sketch. 22.34KB
NEUAppendix 3B11/09/13 download Created with Sketch. 129.14KB
NEUNeuren opens new IND for NNZ-2566 in Fragile X SyndromePRICE SENSITIVE09/09/13 download Created with Sketch. 123.5KB
NEUFinal Director's Interest Notice04/09/13 download Created with Sketch. 9.64KB
NEUNeuren announces changes to its leadership team02/09/13 download Created with Sketch. 134.27KB
NEUHalf Yearly Report and AccountsPRICE SENSITIVE29/08/13 download Created with Sketch. 560.13KB
NEUNotice under section 708A(5)(e) of the Corporations Act05/08/13 download Created with Sketch. 90.75KB
NEUResponse to social media commentary re Rett trialPRICE SENSITIVE05/08/13 download Created with Sketch. 338.1KB
NEUTrading Halt Request05/08/13 download Created with Sketch. 91.66KB
NEUTrading HaltPRICE SENSITIVE05/08/13 download Created with Sketch. 25.94KB
NEUAppendix 4C - quarterlyPRICE SENSITIVE31/07/13 download Created with Sketch. 244.41KB
NEUInvestor presentation July 201330/07/13 download Created with Sketch. 1.23MB
NEUAppendix 3B Option Exercise30/07/13 download Created with Sketch. 648.69KB
NEUResults in Fragile X Model with NNZ 2591PRICE SENSITIVE29/07/13 download Created with Sketch. 465.64KB
NEUResponse to ASX Price QueryPRICE SENSITIVE26/07/13 download Created with Sketch. 137.93KB
NEUNeuren receives two new patentsPRICE SENSITIVE12/07/13 download Created with Sketch. 339.63KB
NEUNotice under section 708A(5)(e) of the Corporations Act11/07/13 download Created with Sketch. 90.72KB
NEUAppendix 3B Option Exercise amended11/07/13 download Created with Sketch. 648.3KB
NEUAppendix 3B Option Exercise11/07/13 download Created with Sketch. 648.26KB
NEUNotice under section 708A(5)(e) of the Corporations Act26/06/13 download Created with Sketch. 90.51KB
NEUAppendix 3B Option Exercise26/06/13 download Created with Sketch. 648.46KB
NEUResponse to ASX Price Query LetterPRICE SENSITIVE25/06/13 download Created with Sketch. 136.75KB
NEUNotice under section 708A(5)(e) of the Corporations Act18/06/13 download Created with Sketch. 90.52KB
NEUAppendix 3B Option Exercise12/06/13 download Created with Sketch. 648.13KB
NEUFDA Fast Track granted for NNZ2566 Rett programPRICE SENSITIVE05/06/13 download Created with Sketch. 347.82KB
NEUChange of Director's Interest Notice29/05/13 download Created with Sketch. 261.17KB
NEUAppendix 3B Equity Performance Rights29/05/13 download Created with Sketch. 650.21KB
NEUAppendix 3B Loan Funded Shares29/05/13 download Created with Sketch. 649.03KB
NEUNotice under section 708A(5)(e) of the Corporations Act29/05/13 download Created with Sketch. 91.07KB
NEUCFO appointment24/05/13 download Created with Sketch. 345.25KB
NEUFinal Director's Interest Notice22/05/13 download Created with Sketch. 231.89KB
NEUFinal Director's Interest Notice22/05/13 download Created with Sketch. 232.68KB
NEUAppendix 3B Exercise of Options22/05/13 download Created with Sketch. 246.91KB
NEULapse of Unlisted Options22/05/13 download Created with Sketch. 85.57KB
NEUChange of Director's Interest Notice22/05/13 download Created with Sketch. 308.57KB
NEUChange of Director's Interest Notice22/05/13 download Created with Sketch. 310.48KB
NEUInvestor Presentation May 201321/05/13 download Created with Sketch. 321.96KB
NEUResults of Meeting20/05/13 download Created with Sketch. 85.88KB
NEUCEO Presentation to AGM20/05/13 download Created with Sketch. 262.64KB
NEUChairman's Address to AGM20/05/13 download Created with Sketch. 204.27KB
NEUResponse to ASX Price Query LetterPRICE SENSITIVE15/05/13 download Created with Sketch. 136.73KB
NEUAppendix 4C - quarterlyPRICE SENSITIVE30/04/13 download Created with Sketch. 244.1KB
NEUNotice of Annual General Meeting/Proxy Form19/04/13 download Created with Sketch. 285.29KB
NEUShareholder UpdatePRICE SENSITIVE15/04/13 download Created with Sketch. 1.05MB
NEUAnnual Report to shareholders28/03/13 download Created with Sketch. 1.4MB
NEUPreliminary Final ReportPRICE SENSITIVE28/02/13 download Created with Sketch. 336.84KB
NEUInitial Director's Interest Notice01/02/13 download Created with Sketch. 230.37KB
NEU Neuren receives ethics approval to start Concussion trial
10/07/14PRICE SENSITIVE download Created with Sketch. 103.23KB
NEU Neuren completes enrolment in Phase 2 trial in Rett Syndrome
26/06/14PRICE SENSITIVE download Created with Sketch. 99.27KB
NEU Appendix 3B
25/06/14 download Created with Sketch. 154.27KB
NEU Neuren appoints CMC expert to leadership team
23/06/14 download Created with Sketch. 107.99KB
NEUNeuren receives new US patent for NNZ-2591
04/06/14PRICE SENSITIVE download Created with Sketch. 94.34KB
NEUAppendix 3B
03/06/14 download Created with Sketch. 157.88KB
NEUAppendix 3B
03/06/14 download Created with Sketch. 157.89KB
NEUAppendix 3B
30/05/14 download Created with Sketch. 154.2KB
NEUNeuren presents at International Meeting for Autism Research
21/05/14 download Created with Sketch. 2.73MB
NEUAppendix 3B
14/05/14 download Created with Sketch. 154.21KB
NEUAppendix 4C - quarterly
30/04/14PRICE SENSITIVE download Created with Sketch. 55.39KB
NEUAppendix 3B
30/04/14 download Created with Sketch. 154.35KB
NEUAGM Results of Meeting
30/04/14 download Created with Sketch. 60.27KB
NEUChairman's AGM Address to Shareholders
30/04/14 download Created with Sketch. 323.39KB
NEUPresentation at Morgans Emerging Companies Conference
02/04/14 download Created with Sketch. 573.38KB
NEUAppendix 3B
27/03/14 download Created with Sketch. 129.34KB
NEUNotice of Annual General Meeting/Proxy Form
27/03/14 download Created with Sketch. 422.95KB
NEUAnnual Report to shareholders
27/03/14 download Created with Sketch. 3.31MB
AAI +S&P DJ Indices Announces March Quarterly Rebalance
07/03/14 download Created with Sketch. 98KB
NEUNeuren reports financial results for 2013
27/02/14 download Created with Sketch. 144.7KB
NEUPreliminary Final Report and audited Financial Statements
27/02/14PRICE SENSITIVE download Created with Sketch. 2.45MB
NEUAppendix 3B
21/02/14 download Created with Sketch. 154.65KB
NEUAppendix 3B
14/02/14 download Created with Sketch. 154.93KB
NEUAppendix 4C - quarterly
31/01/14PRICE SENSITIVE download Created with Sketch. 55.23KB
NEUNeuren reports progress in NNZ-2566 clinical trial programs
28/01/14PRICE SENSITIVE download Created with Sketch. 121.3KB
NEUAppendix 3B
15/01/14 download Created with Sketch. 154.76KB
NEUAppendix 3B
02/01/14 download Created with Sketch. 155.33KB
NEUAppendix 3B
29/11/13 download Created with Sketch. 154.88KB
NEUAppendix 3B
27/11/13 download Created with Sketch. 155.05KB
NEUNeuren Share Purchase Plan raises $2 million
27/11/13 download Created with Sketch. 95.96KB
NEUCeasing to be a substantial holder
20/11/13 download Created with Sketch. 78.04KB
NEUInvestor presentation, 19 November 2013
19/11/13 download Created with Sketch. 331.59KB
NEUAppendix 3B
15/11/13 download Created with Sketch. 155.08KB
NEUChange in substantial holding
14/11/13 download Created with Sketch. 128.51KB
NEUAppendix 3B
12/11/13 download Created with Sketch. 155.24KB
NEUChange of Director's Interest Notice
06/11/13 download Created with Sketch. 35.23KB
NEUShare Purchase Plan record date
04/11/13 download Created with Sketch. 26.48KB
NEUSPP Certification
04/11/13 download Created with Sketch. 36.59KB
NEUAppendix 3B
04/11/13 download Created with Sketch. 155.46KB
NEUBecoming a substantial holder
31/10/13 download Created with Sketch. 147.32KB
NEUShare Purchase Plan offer documents
30/10/13PRICE SENSITIVE download Created with Sketch. 360.05KB
NEUAppendix 4C - quarterly
30/10/13PRICE SENSITIVE download Created with Sketch. 73.31KB
NEUOrphan drug designation from FDA for NNZ-2566 in Fragile X
30/10/13PRICE SENSITIVE download Created with Sketch. 99.4KB
NEUSection 708A(5)e Notice
28/10/13 download Created with Sketch. 27.16KB
NEUAppendix 3B
28/10/13 download Created with Sketch. 155.83KB
NEUPlacement of $21.5m to accelerate execution of strategy
22/10/13PRICE SENSITIVE download Created with Sketch. 101.31KB
NEUNeuren receives Fast Track designation for Fragile X
18/10/13PRICE SENSITIVE download Created with Sketch. 97.96KB
NEUTrading Halt
18/10/13PRICE SENSITIVE download Created with Sketch. 50.9KB
NEUAppendix 3B
10/10/13 download Created with Sketch. 129.23KB
NEUResponse to ASX Price Query
09/10/13PRICE SENSITIVE download Created with Sketch. 75.1KB
NEUInvestor presentation
09/10/13 download Created with Sketch. 680.75KB
NEUNeuren data presented at Fragile X Foundation meeting
01/10/13 download Created with Sketch. 954.86KB
NEUAppendix 3B
26/09/13 download Created with Sketch. 129.09KB
NEUChange of Director's Interest Notice
19/09/13 download Created with Sketch. 22.34KB
NEUAppendix 3B
11/09/13 download Created with Sketch. 129.14KB
NEUNeuren opens new IND for NNZ-2566 in Fragile X Syndrome
09/09/13PRICE SENSITIVE download Created with Sketch. 123.5KB
NEUFinal Director's Interest Notice
04/09/13 download Created with Sketch. 9.64KB
NEUNeuren announces changes to its leadership team
02/09/13 download Created with Sketch. 134.27KB
NEUHalf Yearly Report and Accounts
29/08/13PRICE SENSITIVE download Created with Sketch. 560.13KB
NEUNotice under section 708A(5)(e) of the Corporations Act
05/08/13 download Created with Sketch. 90.75KB
NEUResponse to social media commentary re Rett trial
05/08/13PRICE SENSITIVE download Created with Sketch. 338.1KB
NEUTrading Halt Request
05/08/13 download Created with Sketch. 91.66KB
NEUTrading Halt
05/08/13PRICE SENSITIVE download Created with Sketch. 25.94KB
NEUAppendix 4C - quarterly
31/07/13PRICE SENSITIVE download Created with Sketch. 244.41KB
NEUInvestor presentation July 2013
30/07/13 download Created with Sketch. 1.23MB
NEUAppendix 3B Option Exercise
30/07/13 download Created with Sketch. 648.69KB
NEUResults in Fragile X Model with NNZ 2591
29/07/13PRICE SENSITIVE download Created with Sketch. 465.64KB
NEUResponse to ASX Price Query
26/07/13PRICE SENSITIVE download Created with Sketch. 137.93KB
NEUNeuren receives two new patents
12/07/13PRICE SENSITIVE download Created with Sketch. 339.63KB
NEUNotice under section 708A(5)(e) of the Corporations Act
11/07/13 download Created with Sketch. 90.72KB
NEUAppendix 3B Option Exercise amended
11/07/13 download Created with Sketch. 648.3KB
NEUAppendix 3B Option Exercise
11/07/13 download Created with Sketch. 648.26KB
NEUNotice under section 708A(5)(e) of the Corporations Act
26/06/13 download Created with Sketch. 90.51KB
NEUAppendix 3B Option Exercise
26/06/13 download Created with Sketch. 648.46KB
NEUResponse to ASX Price Query Letter
25/06/13PRICE SENSITIVE download Created with Sketch. 136.75KB
NEUNotice under section 708A(5)(e) of the Corporations Act
18/06/13 download Created with Sketch. 90.52KB
NEUAppendix 3B Option Exercise
12/06/13 download Created with Sketch. 648.13KB
NEUFDA Fast Track granted for NNZ2566 Rett program
05/06/13PRICE SENSITIVE download Created with Sketch. 347.82KB
NEUChange of Director's Interest Notice
29/05/13 download Created with Sketch. 261.17KB
NEUAppendix 3B Equity Performance Rights
29/05/13 download Created with Sketch. 650.21KB
NEUAppendix 3B Loan Funded Shares
29/05/13 download Created with Sketch. 649.03KB
NEUNotice under section 708A(5)(e) of the Corporations Act
29/05/13 download Created with Sketch. 91.07KB
NEUCFO appointment
24/05/13 download Created with Sketch. 345.25KB
NEUFinal Director's Interest Notice
22/05/13 download Created with Sketch. 231.89KB
NEUFinal Director's Interest Notice
22/05/13 download Created with Sketch. 232.68KB
NEUAppendix 3B Exercise of Options
22/05/13 download Created with Sketch. 246.91KB
NEULapse of Unlisted Options
22/05/13 download Created with Sketch. 85.57KB
NEUChange of Director's Interest Notice
22/05/13 download Created with Sketch. 308.57KB
NEUChange of Director's Interest Notice
22/05/13 download Created with Sketch. 310.48KB
NEUInvestor Presentation May 2013
21/05/13 download Created with Sketch. 321.96KB
NEUResults of Meeting
20/05/13 download Created with Sketch. 85.88KB
NEUCEO Presentation to AGM
20/05/13 download Created with Sketch. 262.64KB
NEUChairman's Address to AGM
20/05/13 download Created with Sketch. 204.27KB
NEUResponse to ASX Price Query Letter
15/05/13PRICE SENSITIVE download Created with Sketch. 136.73KB
NEUAppendix 4C - quarterly
30/04/13PRICE SENSITIVE download Created with Sketch. 244.1KB
NEUNotice of Annual General Meeting/Proxy Form
19/04/13 download Created with Sketch. 285.29KB
NEUShareholder Update
15/04/13PRICE SENSITIVE download Created with Sketch. 1.05MB
NEUAnnual Report to shareholders
28/03/13 download Created with Sketch. 1.4MB
NEUPreliminary Final Report
28/02/13PRICE SENSITIVE download Created with Sketch. 336.84KB
NEUInitial Director's Interest Notice
01/02/13 download Created with Sketch. 230.37KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$17.78
Change
0.230(1.31%)
Mkt cap ! $2.240B
Open High Low Value Volume
$17.83 $17.99 $17.35 $16.12M 911.8K

Buyers (Bids)

No. Vol. Price($)
2 11000 $17.40
 

Sellers (Offers)

Price($) Vol. No.
$17.80 10070 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.